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cAMP receptor protein (CRP) plays profound roles in many bacteria as a global regulator. In Escherichia coli, CRPE. coli modu-
lates the expression of many operons involved in carbon catabolism, in response to the fluctuation of intracellular cAMP level 
caused by carbon catabolism. A crp homologue gene has been identified in the genome of Pseudomonas putida, however, little is 
known about its cellular function. In this work, we investigated ligand response properties of this CRP protein (CRPP. putida). The 
results showed that in the presence of exogenous cAMP or cGMP, CRPP. putida can activate the lac promoter in E. coli cya crp 
mutant. In vitro isothermal titration calorimetry (ITC) assays indicated that CRPP. putida could bind cAMP as well as cGMP. Its 
affinity to cAMP is much higher than CRPE. coli. Sequence alignment of the CRP proteins suggested that the Thr132 of CRPP. putida 
(analogous to Ser128 of CRPE. coli) could be the key determinant for all ligand responsive properties observed above. When 
Thr132 of CRPP. putida is mutated to Serine, two phenomena were observed: (i) its affinity to cAMP or cGMP was reduced to a 
level similar to CRPE. coli; (ii) its transcriptional activation activity on E. coli lac promoter was diminished. The potential physio-
logical implications of these ligand binding properties are discussed. 
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cAMP receptor protein (CRP), a key member of CRP-FNR 
family, is widely distributed in prokaryotes, acting as a 
global regulator [1]. CRP proteins exert regulatory effect in 
the process of carbon metabolism, nitrogen assimilation, 
photosynthesis and virulence factor regulation [2–4]. The 
CRP protein of Escherichia coli (CRPE. coli) is probably the 
best-characterized protein in the CRP-FNR family. It regu-
lates the transcription of more than 200 genes in E. coli [5]. 
Upon cAMP binding, CRPE. coli undergoes certain confor-
mational changes, which in turn facilitate recognition of 
specific DNA target site. When it is the sole activator, DNA 
target site bound CRPE. coli interacts with RNA polymerase 
holoenzyme (RNAP), and recruits RNAP to the target pro-
moter, which in turn initiates gene transcription [6]. CRPE. coli 
functions as a dimer of approximately 47 kD. Each mono-
mer can bind two molecules of cAMP [7]. It consists of 209 
amino acid residues and two major structural domains. The 
N-terminal domain (residues 1–133) contains a cAMP- 
binding hydrophobic pocket and the C-terminal domain 
(residues 139–209) contains the DNA recognition motif [8]. 
The consensus sequence of CRPE. coli binding site is 
AAATGTGAN6TCACATTT, a 22-base motif containing 
an inverted repeat [9].  
In E. coli, as the allosteric ligand of CRP protein, cAMP 
is synthesized by the adenylate cyclase encoded by cyaA. 
Intracellular cAMP concentration is tightly controlled and 
fluctuates significantly in response to quality change of 
carbon source. This control is achieved by the phosphoe-
nolpyruvate-dependent phosphotransferase system (PTS). 
When cells are grown on the PTS carbon source such as 
glucose, cAMP level stays low and CRPE. coli exerts little 
activity. Intracellular cAMP level increases dramatically 
when cells are grown on the non-PTS carbohydrates, and 
subsequently the activity of CRPE. coli is triggered by cAMP 
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binding. Genes related to carbohydrate metabolism such as 
lactose, galactose and arabinose are activated by CRPE. coli- 
cAMP [10]. Meanwhile, key operons like glnALG and 
glnHPQ which encode crucial proteins in nitrogen acquisi-
tion and ammonium assimilation, are proven to be regulated 
by the complex as well [4,11]. High through-put genomic 
analysis confirmed that the CRPE. coli-cAMP complex par-
ticipates mostly in the regulation of genes which involved in 
the transport and metabolism of carbon and nitrogen source 
[5]. Although CRPE. coli can bind cGMP, no evidences show 
that cGMP-binding could induce CRPE. coli’s conformational 
change required for DNA binding and transcriptional regu-
lation [12]. 
The genus Pseudomonas comprises a group of strains 
that have profound environmental or pathogenic relevance. 
Pseudomonas putida is a widely studied pseudomonad for 
its potential application in bioremediation and biodegrada-
tion. Its genome encodes a CRP ortholog (PP_0424) that 
shares 62% identity and 80% similarity with the E. coli 
counterpart [13]. These two proteins share the similar 
cAMP binding pocket for ligand recognition and helix- 
turn-helix (HTH) motif for DNA binding. However, their 
physiological roles seem to be quite different [14]. In P. 
putida strain KT2440 (strain mt-2 deprived of mega- plas-
mid pWW0), CRPP. putida plays a role in the utilization of 
several dipeptide as nutrients and has little influence on the 
carbon source metabolism [14]. In P. putida strain 
DOT-T1E, a crp mutant was unable to grow in the medium 
with ammonium as sole nitrogen source [15]. Therefore, the 
physiological role of CRPP. putida is probably related to the 
nitrogen metabolism rather than the carbon metabolism. 
Intracellular cAMP in P. putida is produced by the enzyme 
encoded by the cyaA ortholog (PP_5222, CyaAP. putida) [14]. 
The mutual dependence of CyaAP. putida and CRPP. putida for 
full regulatory function was established recently [14]. Fol-
lowing recent discovery of the existence of cGMP in bacte-
ria [16], evidences have elucidated that members of CRP 
family protein respond to cGMP or c-di-GMP [17–19], 
suggesting cyclic nucleotide other than cAMP might have 
important roles in binding CRP homologues. 
In this study, we characterized the signal responsive 
properties of CRPP. putida, and significant deviation was 
ovserved compared to CRPE. coli. Further determination of key 
residues for signal responsive properties was also carried out. 
1  Materials and methods 
1.1  Strains, plasmids and media 
The bacterial strains and plasmids used in this work are 
listed in Table 1. The crp cyaA double mutant strains, 
BD7000 and BD8000, were constructed from E. coli 
MG1655 or BL21(DE3) respectively by P1 transduction. 
The donor strains (JW3778-3 and JW5702-4) were pur-
chased from the Coli Genetic Stock Center. Briefly, lysates 
were first generated by growing P1vir phage on the 
JW3778-3 and JW5702-4. The resulting lysate of JW3778-3 
was used to incubate with MG1655 or BL21(DE3) to con-
struct the MG1655 ΔcyaA or BL21(DE3) ΔcyaA mutant, 
then the lysate of JW5702-4 was applied subsequently to 
MG1655 ΔcyaA or BL21(DE3) ΔcyaA strain to get the final 
BD7000 or BD8000. 
For routine growth, bacteria were grown at 37°C (for E. 
coli) or 30°C (for P. putida) in Luria-Bertani (LB) broth. 
For β-galactosidase assay, bacteria were grown in minimal 
M9 medium with 0.4% glucose as carbon source and 1 
mmol L−1 IPTG was added for expression of the CRP pro-
teins. For the protein preparation, strains were grown in M9 
medium supplemented with 1% glucose and 0.4% casamino 
acid (Difco) at 30°C.  
1.2  Recombinant DNA techniques 
Preparation of chromosomal and plasmid DNA, PCR am-
plification, restriction enzyme digestions, ligations and 
transformations were performed as described [23]. The 
site-directed mutagenesis of CRP was done by using the 
QuickChange® Site-Directed Mutagenesis Kit (Stratagene). 
In brief, two complementary primers (listed below) con-
taining the desired mutation were applied for PCR amplifi-
cation using pKU9401 as template. Subsequently, the PCR 
mixture was digested with DpnI and transformed into 
TOP10 competent cell (Invitrogen). The resulting plasmids 
containing the DNA fragments with specific mutation were 
verified by sequencing. The primers used are: p1, 5′-CGCC- 
TGCGCAACACTTCACGCAAGGTTGGCGATT-3′; p2: 5′- 
AATCGCCAACCTTGCGTGAAGTGTTGCGCAGGCG-3′ 
(for CRPP. putida T132S construct); p3: 5′-GAGCTAGGCCT- 
GTTCGAGGATGGCCAGCAGCGCAGTGCCTGG-3′; p4: 
5′-CCAGGCACTGCGCTGCTGGCCATCCTCGAACAG-  
GCCTAGCTC-3′ (for CRPP. putida Iex construct). 
1.3  Enzyme assays 
The β-galactosidase activity assay was carried out as de-
scribed by Miller [24]. 
1.4  Protein, antibody preparation and Western blot 
To purify CRP and the mutant proteins, crp and derivative 
mutant genes were PCR amplified and cloned into the ex-
pression vector pET28a (Novagen) between Nde I and Hind 
III sites. Confirmed by sequencing, the resulting plasmids 
(pKU9800, pKU9801, pKU9802 and pKU9810) were in-
troduced into expression strain BD8000. To express the 
protein, the strain was pre-grown overnight in M9 liquid 
medium. The overnight culture was diluted 1:100 into fresh 
M9 medium and grown at 30°C. At A600 of 0.5, IPTG was 
added to a final concentration of 0.5 mmol L–1. After 6 h 
induction, cells were collected by centrifugation. The pellet  
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Table 1  Bacterial strains and plasmids 
Strains or plasmids Characteristics Source 
Strains   
Escherichia coli   
MG1655 F– lambda- ilvG- rfb-50 rph-1 Lab stock 
TOP10 F– mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 nupG recA1 araD139 ∆(ara-leu)7697 galE15 
galK16 rpsL(Strr) endA1  
Invitrogen 
BL21(DE3) F– ompT hsdSB(rB− mB−) gal dcm (DE3) Novagen 
JW3778-3 F– ∆(araD-araB)567 ∆lacZ4787(: rrnB-3) &lambda- rph-1 ∆cyaA751: kan ∆(rhaD-rhaB)568 hsdR514 [20] 
JW5702-4 F– ∆(araD-araB)567 ∆lacZ4787(: rrnB-3) &lambda- ∆crp-765: kan rph-1 ∆(rhaD-rhaB)568 hsdR514 [20] 
BD7000 MG1655 ∆crp ∆cyaA This work 
BD8000 BL21(DE3) ∆crp ∆cyaA This work 
Pseudomonas putida   
mt-2 Wild type [21] 
Plasmids   
pVTRA’ pSC101 derivative, lacIq-Ptac expression vector, Cmr [22] 
pET28a Histag overexpression vector, Kanr Novagen 
pBluescript-SK ColE1, lacZ’, Apr Stratagene 
pKU9401 pBluescript containing P. putida crp gene, Apr This work 
pKU9500 pVTRA’ derivative encoding CRPE. coli, Cmr This work 
pKU9600 pVTRA’ derivative encoding CRPP. putida, Cmr This work 
pKU9601 pVTRA’ derivative encoding CRPP. putida T132S, Cmr This work 
pKU9800 pET28a derivative expressing His-tagged CRPP. putida, Kanr This work 
pKU9801 pET28a derivative expressing His-tagged CRPP. putida T132S, Kanr This work 
pKU9802 pET28a derivative expressing His-tagged CRPP. putida Iex (the three additional residues in cAMP binding 
pocket were deleted) Kanr 
This work 
pKU9810 pET28a derivative expressing His-tagged CRPE. coli, Kan
r This work 
 
 
was resuspended in buffer A (50 mmol L–1 Tris, pH 7.4, 500 
mmol L–1 NaCl, 20 mmol L–1 imidazole, 1 mmol L–1 DTT)  
and disrupted by sonication (approx. 200 W for 5 min on ice 
of 10 s ON and 10 s OFF mode). Cell debris was removed 
by centrifugation and the supernatant was passed through a 
HisTrap Nickel affinity column (GE Healthcare). After 
washing with buffer A, the proteins were eluted by buffer A 
supplemented with 400 mmol L–1 imidazole. The eluted 
fractions were then applied to a Superdex 75 gel filtration 
column (GE Healthcare). Protein purity was verified by 
SDS-PAGE followed by Coomassie blue staining. The puri-
fication procedures of CRPE. coli, CRPP. putida and the mutants 
were identical as described above. The polyclonal antibody 
of CRPE. coli was from lab storage. The polyclonal antibody 
of CRPP. putida was obtained from the rabbit serum after 45 d 
of immunization by 4 times’ purified CRPP. putida protein 
injection. The secondary antibody (Goat anti Rabbit IgG 
HRP) was purchased from Santa Cruz Biotechnology, Inc. 
Western blot was performed according to the standard pro-
cedure [23]. Quantification of the intensity of protein bands 
was done by using Quantity One software (Bio-Rad). 
1.5  Isothermal titration calorimetry 
The protein solution was extensively dialyzed against Tris 
buffer (50 mmol L–1 Tris, pH 7.4, 500 mmol L–1 NaCl) and 
the nucleotide was solved directly in Tris buffer. The ITC 
measurements were carried out using a MicroCal iTC200 
calorimeter (GE Healthcare) at 25°C. In brief, 19 injections 
of 2 μL nucleotide solutions (2 mmol L–1) were introduced 
at 2-min intervals into the sample cell containing 200 μL 
CRP or the mutants (0.1–0.2 mmol L–1) with constant stir-
ring at 1000 r min–1, and the heat changes accompanying the 
additions were recorded. The data were fitted with the 
one-site model (except CRPE. coli with cAMP, which was 
fitted with the two-site model) to calculate the association 
constant (Ka) using the MicroCal ORIGIN 7.0 software. 
2  Results 
2.1  In vivo assay reveals that CRPP. putida has versatile 
ligand dependency and sensitivity 
In order to investigate the role of P. putida CRP as a tran-
scription factor, plasmid expressing CRPP. putida was intro-
duced into the crp cya double mutant E. coli strain BD7000. 
In vivo activity of the chromosomal lac promoter was mon-
itored by β-galactosidase assay, when cells were grown in 
M9 medium supplemented with 1 mmol L–1 cAMP or 
cGMP. As shown in Figure 1(a) and Figure 2, CRPP. putida 
could activate the lac promoter in response to exogenous 
cAMP or cGMP in E. coli, while CRPE. coli responded only 
to cAMP. Surprisingly, substantial lac promoter activity 
was observed in the strain expressing CRPP. putida even under 
the condition without any exogenous ligand was supplied in 
the medium. This result indicated that CRPP. putida might  
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Figure 1  Constantly expressed CRP proteins activate lac promoter in 
response to titrated exogenous cAMP in E. coli. (a) E. coli strain BD7000 
expressing CRPE. coli, CRPP. putida or CRPP. putida T132S were grown in M9 
medium supplemented with 1, 0.5, 0.1, 0.01 and 0 mmol L–1 exogenous 
cAMP. β-galactosidase activity was measured at the mid-log growth phase. 
Circle, CRPE. coli; square, CRPP. putida; triangle, CRPP. putida T132S. (b) The 
upper portion shows Western blot analysis of the strains described above 
using CRPP. putida or CRPE. coli polyclonal antibody. The amounts of loading 
were normalized based on the concentration of the total protein. Lanes 1–5: 
1, 0.5, 0.1, 0.01, 0 mmol L–1 exogenous cAMP added respectively; the 
bottom portion illustrates the relative intensity of protein bands.  
 
 
Figure 2  Exogenous cGMP triggers the activity of CRPP. putida but not   
CRPE. coli or CRPP. putida T132S for activating lac promoter in E. coli. E. coli 
strain BD7000 was grown in M9 medium in the presence (black bar) or ab-
sence (white bar) of 1 mmol L–1 cGMP. EcCRP, CRPE. coli; PpCRP, CRPP. putida. 
exert its activity independent of cAMP or cGMP.  
In vivo activity assay with titrated exogenous cAMP  
further demonstrated that much less cAMP was required for 
CRPP. putida to activate the lac promoter. In strains containing 
CRPP. putida, lac promoter activity was saturated promptly in 
the presence of less than 0.1 mmol L–1 cAMP. In contrast, 
in strains expressing CRPE. coli, the promoter activity in-
creased gradually and could not be maximized even in the 
presence of 1 mmol L–1 cAMP (Figure 1(a)). In order to rule 
out the possibility of difference in intracellular protein level, 
Western blots was performed to examine the expressing level 
of proteins (Figure 1(b)). The levels of CRP proteins in every 
strain tested above were almost the same, suggesting that it 
was molecular property but not expression level that gave rise 
to the differences between these two proteins. Taken together, 
these results revealed that CRPP. putida could act as a transcrip-
tional regulator and possessed versatile ligand dependency 
and sensitivity than its E. coli counterpart. 
2.2  CRPP. putida displays ultra-high affinity with cAMP 
in vitro 
For the purpose of validating the in vivo results described 
above, in vitro ITC analysis was performed to calculate the 
binding parameters of CRP proteins towards cAMP and 
cGMP. The purified CRPP. putida solution was mixed with 
either titrated cAMP or cGMP at 25°C (see Materials and 
methods), and the heat change upon binding was measured 
(Table 2). As shown in Figure 3(a), CRPP. putida has a strong 
affinity to cAMP, with an approximately 1:1 stoichiometry 
and an estimated association constant (Ka) of (1.29±0.18)  
× 107 (mol L–1)–1. In contrast, CRPE. coli bound to cAMP with 
a much lower association constant of (2.3±0.22) × 105  
(mol L–1)–1 (Figure 3(c)), which was similar with the data 
previously reported [8,25]. These results indicated that 
CRPP. putida was much more sensitive to cAMP signal than 
CRPE. coli, which was consistent with the observation in the 
in vivo assay above. 
Since cGMP could induce the activity of CRPP. putida in 
the in vivo assay above, the binding stoichiometry and af-
finity of CRP proteins to cGMP was determined by in vitro 
ITC analysis as well. As shown in Figure 3(b), the interac-
tion between CRPP. putida and cGMP fitted one-site binding 
model and the association constant was (1.01±0.06) × 105 
(mol L–1)–1, 100 times lower than the interaction between 
CRPP. putida and cAMP. The association constant of CRPE. coli 
and cGMP was (1.77±0.13) × 104 (mol L–1)–1 (Figure 3(d)). 
Taken in vitro and in vivo assay data together, cAMP, but 
not cGMP, was the preferable signal ligand for CRPP. putida 
to conduct its biological function. 
2.3  Thr132 is crucial for both high cAMP affinity and 
cGMP binding of CRPP. putida 
As a first step to identify the determinant residues that caused 
the distinct property of CRPP. putida, sequence alignment was 
made to compare the differences between CRPP. putida and 
CRPE. coli, particularly around the positions involved in di-
rect cAMP or DNA binding (Figure 4). Two major dissimi-
larities were found in these two proteins: (i) CRPP. putida  
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Table 2  ITC isothermal parameters of CRPP. putida, CRPP. putida T132S and CRPP. putida Iex binding to cAMP or cGMP 
 Ligand Na) Ka ((mol L
–1)−1) ∆H (cal mol–1) ∆S cal mol–1 deg–1 
CRPP. putida cAMP 0.826±0.002 (1.29±0.18) × 10
7 –2886±12.45 22.9 
cGMP 0.845±0.006 (1.01±0.06) × 105 –6226±63.42 2.01 
CRPP. putida T132S cAMP 0.556±0.011 (2.36±0.50) × 10
5 –3244±90.67 13.7 
cGMP 0.743±0.012 (3.70±0.25) × 104 –4730±110.5 5.04 
CRPP. putida Iex cAMP 0.709±0.004 (2.69±1.02) × 10
7 –5192±63.19 16.6 
 cGMP 0.724±0.013 (1.76±0.29) × 105 –6906±183.2 0.832 




Figure 3  ITC analysis of cAMP and cGMP binding to CRPE. coli or CRPP. putida. (a) ITC assay of 0.2 mmol L–1 CRPP. putida with 2 mmol L–1 cAMP in Tris 
buffer; (b) 0.2 mmol L–1 CRPP. putida with 2 mmol L
–1 cGMP; (c) 0.1 mmol L–1 CRPE. coli with 2 mmol L
–1 cAMP; (d) 0.2 mmol L–1 CRPE. coli with 10 mmol L
–1 
cGMP. Data from (a), (b) and (d) are best fitted with one-site binding model, data from (c) are best fitted with two-site binding model. 
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contained three more residues (Pro79, Val80 and Glu83) in 
the cAMP binding pocket region; (ii) Thr132 of CRPP. putida 
was replaced by Ser at the corresponding position of 128 in 
CRPE. coli. In order to verify the contribution of these resi-
dues, site-directed mutagenesis was carried out and the re-
sulting mutant protein was subjected to ITC analysis. As 
shown in Figure 5(c), (d) and Table 2, deletion of the three 
additional residues (designated as CRPP. putida Iex) had no 
influence on the ligand responsiveness. In contrast, the 
CRPP. putida T132S mutant showed incredible low cAMP 
affinity, almost two orders of magnitude’s decrease (Figure 
5(a), Table 2); The cGMP association constant of CRPP. putida 
T132S dropped to the level below the physiological signifi-
cance (Figure 5(b), Table 2). Both constants above were 
almost the same as CRPE. coli, which was (2.3±0.22) × 10
5 or 
(1.77±0.13) × 104 (mol L–1)−1 in the control experiments 
with cAMP or cGMP, respectively (Figure 3(c) and (d)). In 
consistence with in vitro assay, when CRPP. putida T132S was 
introduced into the cya crp double mutant E. coli strain, the 
lac promoter activity remained at very low level along with 
titrated exogenous cAMP and exhibited unresponsiveness to 
cGMP (Figures 1(a) and 2). All these data above suggested 
that the ligand binding properties of CRPP. putida T132S were 
nearly identical to those of CRPE. coli [25], and the residue 
Thr132 was the key factor that influence the ligand binding 
properties of CRPP. putida. 
3  Discussion 
In this study, we demonstrated that CRP proteins from P. 
putida possess versatile ligand binding properties. CRPP. putida 
has almost 100-fold higher cAMP affinity than CRPE. coli. 
This implies that CRPP. putida requires less intracellular 
cAMP than CRPE. coli to maintain its function. It is reported 
that unlike E. coli, in which the intracellular cAMP concen-
tration fluctuates dramatically [27], cAMP level in Pseu-
domonas stays extremely low and stable [28,29]. This phe-
nomenon might due to the weak adenylate cyclase activity 
[14] or the effect of more than one active phosphodiesteras-
es in Pseudomonas [30]. Therefore, the ligand binding af-
finity of CRPP. putida may adapt to much lower concentration 
of intracellular cAMP.  
The question about how many ligand binding sites are 
present in one CRP subunit has not been completely deter-
mined to date [25,31,32]. In any case, it is evident that large 
cAMP-induced conformational change is required for  
CRPE. coli’s binding to target DNA site [33]. The structural 
modeling of CRPP. putida using CRPE. coli as template indicates 
slight structural difference between these proteins within the 
cAMP and DNA binding domain. Our observations based 
on the proteolytic digestion pattern of CRPP. putida with or 
without ligand suggest that CRPP. putida undergoes a confor-
mational transition upon cAMP binding. It is probably that 
similar conformational change (just like CRPE. coli) occurs to 
cAMP-bound CRPP. putida, which dramatically facilitates the 
protein-DNA interaction. Anyhow, it is evident that   
CRPP. putida displays higher affinity with cAMP in one-site 
model in vitro and activates promoter activity in vivo in the 
presence of cAMP. 
The responsiveness of CRPP. putida towards cGMP is in-
triguing as well. As discussed above, cGMP could trigger 
the activity of CRPP. putida. Actually, cGMP is previously 
considered to be capable of activate VFR, a CRP homolog 
in Pseudomonas aeruginosa [34]. Recent work argues that 
cGMP is unlikely to play a biological role in VFR binding 
[35]. Consequently, we believe the situation should be the 
same in CRPP. putida, as conditions containing such a high 
cGMP concentration can hardly be found in the environ-
ment. The capability of binding cGMP is probably a 
by-product of CRPP. putida’s evolutionary shift to high cAMP 
affinity. Another consequence of this shift would be the 
presence of CRPP. putida activity in the absence of cNMP 
(Figures 1(a) and 2). The similar property is also discovered 
in VFR, which regulated the lasR promoter through cAMP- 
dependent and -independent mechanisms [35].  
While the manuscript was submitted, a paper was pub-
lished ahead online and showed that a MBP-CRPP. putida  
 
 
Figure 4  Sequence alignment of CRP protein from E. coli and P. putida. Star, residues participated in cAMP binding [2]; diamond, residues involved in 
stabilizing the cAMP binding pocket [2]; triangle, residues which directly contact with nucleotides in the binding site [26]; underlined, residues participated 
in the CRP-RNAP interaction [8]. Open circle, three additional residues in the cAMP binding pocket of CRPP. putida compared with CRPE. coli. EcCRP,   
CRPE. coli; PpCRP, CRPP. putida. 
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Figure 5  ITC analysis of cAMP and cGMP binding to CRPP. putida mutants. (a) 0.2 mmol L–1 CRPP. putida T132S with 1 mmol L–1 cAMP; (b) 0.2 mmol L–1 
CRPP. putida T132S with 2 mmol L
–1 cGMP; (c) 0.2 mmol L–1 CRPP. putida Iex with 2 mmol L
–1 cAMP; (d) 0.2 mmol L–1 CRPP. putida Iex with 2 mmol L
–1 cGMP. 
All data are best fitted with one-site binding model. 
fusion protein possesses high binding affinity for cAMP in 
vitro [36]. In addition to confirming the CRPP. putida’s ultra-
high cAMP responsiveness, this work has demonstrated the 
role of a key residue associated with ligand binding and 
promoter activation. The results obtained from the    
CRPP. putida T132S mutant reveal that the Thr132 residue is 
responsible for all the signal sensing properties discussed 
above. Previous work has proved that the S128T mutation 
of CRPE. coli at the equivalent position could make the pro-
tein sensitive to cGMP without changing the cAMP binding 
affinity [37]. It might be speculated that the Thr132 residue 
has altered CRPP. putida’s cAMP binding pocket a better 
space structure to accommodate cGMP for activation. The 
substitution of Thr132 to Ser should have caused somewhat 
modest conformational change, because of which remarka-
ble loss of cAMP and cGMP affinities are taken place. Our 
preliminary data with multiple sequence alignments show 
that in genus Pseudomonas, nearly 90% residues at the po-
sition 132 are Thr; whereas in Enterobacteria, 90% remain 
Ser at this equivalent site. These interesting observations 
might be coincidental to meet the reality that the distinct 
ligand binding properties of CRP proteins originate from the 
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diverse amino acid residues at this position. In conclusion,    
CRPP. putida demonstrates a high level of cAMP affinity, and 
Thr132 residue of CRPP. putida plays important role in such 
ligand binding properties. A detailed study is expected to 
understand the reason of why it needs such unusual signal 
sensing properties.  
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